Flaharty Asset Management, LLC Bio Atla, Inc. Transaction History
Flaharty Asset Management, LLC
- $639 Million
- Q1 2025
A detailed history of Flaharty Asset Management, LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Flaharty Asset Management, LLC holds 4,150 shares of BCAB stock, worth $1,743. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,150Holding current value
$1,743% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCAB
# of Institutions
46Shares Held
13.9MCall Options Held
20.3KPut Options Held
1.2K-
Acorn Capital Advisors, LLC New York, NY4.03MShares$1.69 Million0.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.82MShares$763,5600.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.69MShares$709,8460.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.37MShares$577,1110.03% of portfolio
-
Black Rock Inc. New York, NY792KShares$332,4550.0% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $15.2M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...